Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone induction methods in rapid opioid detoxification
NCT02362256Completed
- Sponsor
- Vilnius University
- Start
- May 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of naltrexone in opioid use disorder (OUD), sponsored by Vilnius University. Primary endpoints: Cortisol levels at 2 days and Adrenocorticotropic hormone levels at 2 days. Started May 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02362256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362256.